DLEU1（13q14）基因探针
| 型 号： | |
| 报 价： |  |
DLEU1（13q14）基因探针 本试剂盒主要用于DLEU1（13q14）基因的检测，里面包括即用型杂交液和DAPI复染剂。 本试剂盒仅供科研使用。
- 产品描述
DLEU1（13q14）基因探针
广州健仑生物科技?有限公司
本司长期供应尼古丁（可替宁）检测试剂盒，其主要品牌包括美国NovaBios、广州健仑、广州创仑等进口产品，国产产品，试剂盒的实验方法是胶体金方法。
我司还有很多荧光原位杂交系列检测试剂盒以及各种FISH基因探针和染色体探针等，。
DLEU1（13q14）基因探针
本试剂盒主要用于DLEU1（13q14）基因的检测，里面包括即用型杂交液和DAPI复染剂。
本试剂盒仅供科研使用。
欢迎咨询
欢迎咨询
以下是我司出售的部分FISH产品：
| BCL6（3q37）基因断裂探针 |
| 13/18/21/XY染色体计数探针 |
| XY染色体计数探针 |
| p53/RB1/ATM/CSP12/D13S25基因探针 |
| 5q33/5q31/D7S486/D7S522/CSP8/D20S108/XY基因探针 |
| 4/10/17/KMT2A[ETV6RUNX1]/[BCRABL(DF)]基因探针 |
| p53/D13S319/RB1/1q21/IGH基因探针 |
| 13/16/18/21/22/XY染色体计数探针 |
| ALK（2p23）基因断裂探针 |
| EML4/ALK融合基因 t(2;2); inv(2) 探针 |
| 1p和19q探针 |
| KIT（4q12）基因探针（红色） |
| SS18（18q11）（SYT）基因断裂探针 |
| 乳腺癌染色体数目异常检测探针 |
| C-MET（7q31）基因探针 |
二维码扫一扫
【公司名称】 广州健仑生物科技有限公司
【】 杨永汉
【】
【腾讯 】
【公司地址】 广州清华科技园创新基地番禺石楼镇创启路63号二期2幢101-3室
【企业文化宣传】
Mr. Huang said that the special drug for treating Bray was actually listed in foreign countries as early as 2001, but has not been in the Chinese market. "This drug can not be bought at home, and in foreign countries is particularly expensive, even if bought can not afford to buy." Mr. Huang said.
Some rare diseases
Be included in the category of free aid
The reporter has learned that in recent years, with the attention of media, medical institutions, public welfare organizations and relevant government departments, more and more rare diseases have been gradually known to the public. Some rare diseases have also been paid attention to and are included in the category of free assistance.
Insiders said that the gene detection technique can effectively diagnosis and prevention of rare diseases in a certain range, the Mediterranean anemia, congenital deafness, maple diabetes, adrenal hyperplasia, ichthyosis, Duchenne muscular dystrophy, single gene genetic disease, can realize the "early warning" in the pre stage through genetic testing; congenital retinal ten pigmentosa rare disease, can be treated by gene technology; including phenylketonuria, hundreds of genetic diseases can be accuray diagnosed by gene detection technology, in order to intervene by diet and drugs etc. in daily life.
Ms. Chen, the care home of CMT (peroneal muscular atrophy), said he hoped that the public would be able to know and pay attention to rare diseases. Taking CMT as an example, the current organization found only 500 patients in the country. On the one hand, she hopes that the patient will face up to his illness, diagnose the disease and prevent the disease from being inherited. On the other hand, the data of the sick friend are very important for future drug research, pricing and health insurance.
